SCHEMBL1422658

SCHEMBL1422658

Clc1ccc2cc(-c3ccc(-n4ccnc4)nc3)[nH]c2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 1/20 0.40
IDH1 O75874 2/20 0.39
IDO1 P14902 3/20 0.39
NPC1 O15118 2/20 0.38
ALDH1A1 P00352 2/20 0.38
CYP1A2 P05177 2/20 0.38
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38
MAPT P10636 1/20 0.38
CYP2C9 P11712 1/20 0.38
HPGD P15428 1/20 0.38
CYP2C19 P33261 1/20 0.38
CASP3 P42574 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 1/20 0.38
SENP8 Q96LD8 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
SENP6 Q9GZR1 1/20 0.38
CYP19A1 P11511 3/20 0.38
NOTUM Q6P988 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13577817 0.86 PIM1 (0.40) PIM1ALDH1A1CYP1A2KDM4EMAPT
SCHEMBL1484074 0.86 GAA (0.42) PIM1ALDH1A1CYP1A2KDM4EMAPT
SCHEMBL1484008 0.83 CYP11B1 (0.48) NPC1ALDH1A1CYP1A2KDM4EMEN1
SCHEMBL1421155 0.83 CYP19A1 (0.46) PIM1ALDH1A1CYP1A2CYP2C19CYP19A1
SCHEMBL1422916 0.80 CYP1A1 (0.45) PIM1IDH1IDO1ALDH1A1CYP1A2
SCHEMBL1483695 0.79 KDM4E (0.40) PIM1NPC1ALDH1A1CYP1A2KDM4E
SCHEMBL13577804 0.79 PIM1 (0.40) PIM1IDH1NPC1ALDH1A1CYP1A2
SCHEMBL1484209 0.79 CYP19A1 (0.46) PIM1IDO1ALDH1A1CYP1A2CYP19A1
SCHEMBL1483709 0.79 GAA (0.42) PIM1IDH1IDO1NPC1ALDH1A1
SCHEMBL1422837 0.79 CDK5 (0.52) PIM1IDO1CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110076230-A1 Novel Substituted Indoles MERCK & CO. INC. 2011-03-31 US claimed
EP-2296474-A1 NOVEL SUBSTITUTED INDOLES Merck Sharp & Dohme Corp. (US) 2011-03-23 EP claimed
WO-2009155024-A1 NOVEL SUBSTITUTED INDOLES MERCK & CO., INC. (US) 2009-12-23 WO claimed
US-20110076230-A1 Novel Substituted Indoles MERCK & CO. INC. 2011-03-31 US disclosed
US-20110076230-A1 Novel Substituted Indoles MERCK & CO. INC. 2011-03-31 US disclosed
US-20110076230-A1 Novel Substituted Indoles MERCK & CO. INC. 2011-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110076230-A1 Novel Substituted Indoles APP, BACE1, PSEN1 PIM1 489/4885IDH1 1016/4885IDO1 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.